MedTrace Logo

Fluorescent Visualization in Early Oral Cancer

NCT02306967 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-05-02

No results posted yet for this study

Summary

Studies from Vancouver show that fluorescent visualization (FV) is a useful method of controlling surgical margins. This early finding will now be confirmed in a national randomized controlled trial.

Conditions

  • Oral Squamous Cell Carcinoma or Severe Dysplasia

Interventions

PROCEDURE

resection of oral cancer

Oral cancer will be resected.

PROCEDURE

resection of oral cancer

Oral cancer will be resected

Sponsors & Collaborators

  • Terry Fox Research Institute

    collaborator OTHER

  • University of Calgary

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2017-10-31
Completion
2017-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02306967 on ClinicalTrials.gov